CeGaT Genetic Laboratory in Germany is Europe's largest company in the field of clinical genetics. It specializes in genetic research in oncology, neurology, ophthalmology, cardiology, and reproductive medicine. CeGaT is recognized as the world's leading provider of gene analysis. The laboratory performs high-quality tests, which are confirmed by CAP, CLIA, and ISO15189 certificates and accreditations, as well as participation in EMQN and CAP interlaboratory blind testing.
CeGaT Laboratory supports physicians and patients in the search for the genetic causes of rare diseases. Pharmaceutical companies are benefiting from the genetic analysis, clinical trials, and medical innovations of CeGaT.
The headquarters of CeGaT Laboratory is located in the city of Tubingen (Germany), with affiliations in Chicago (USA) and Beijing (PRC).
The founder of CeGaT Genetic Laboratory, Saskia Bishop, MD, researcher and bioinformatician, has received numerous international awards in genetic research in Parkinson's disease.
CeGaT has several advantages over other genetic laboratories. Among them:
Genetic research is constantly improving and may be revised to reflect the progress of scientific evidence. In the event of such a reassessment, CeGaT Laboratory informs the attending physicians. The re-evaluated variant will be interpreted by CeGaT specialists, taking into account the patient's clinical picture. The revised medical opinion for the patient at CeGaT will be free of charge.
More than 200 types of genetic and transcriptomic analyses are performed in German Laboratory CeGaT in various areas, including:
This helps to enhance the therapeutic effect and minimize damage to healthy tissues. In addition, a study of genes responsible for an increased risk of developing breast, ovarian, uterine, and prostate cancers is performed.
The genetic studies data in CeGaT are processed within 2-3 weeks, after which the patient receives a medical opinion. An interdisciplinary team of molecular biologists and CeGaT specialists preliminarily discusses it. In the conclusion, the recommended methods of treatment are indicated.
Patients can go to the nearest laboratory at their place of residence for blood sampling. To send material for research to CeGat, contact the doctors-coordinators of Experts Medical. To do this, leave a request on this website.
Based on the diagnostic results, Experts Medical coordinators can arrange an online consultation with a highly specialized doctor in a foreign clinic and a treatment abroad.
All
Oncology
Medical genetic consultancy | 200 € | Enquire price |
Disease-related gene-sets | 875 - 1350 € | Enquire price |
Colorectal Cancer | 875 - 1200 € | Enquire price |
Gastric Cancer | 1200 € | Enquire price |
Cowden Syndrome | 875 € | Enquire price |
Pancreatic cancer | 1200 € | Enquire price |
Breast and Ovarian Cancer | 1200 - 1350 € | Enquire price |
Tumors of the Central Nervous System | 1200 € | Enquire price |
Renal cell carcinoma | 1200 € | Enquire price |
Prostate Cancer | 1200 € | Enquire price |
Pheochromocytoma and Paraganglioma | 1200 € | Enquire price |
Xeroderma pigmentosum | 875 € | Enquire price |
Melanoma | 800 - 1200 € | Enquire price |
Breast and Ovarian Cancer BRCA 1 / BRCA 2 | 600 - 900 € | Enquire price |
Tumor Immuno-Oncology Analysis (TMB and MSI) | 1950 € | Enquire price |
Somatic tumor panel for treatment decision support | 2950 € | Enquire price |
Lung carcinoma | 1000 € | Enquire price |
Colorectal carcinoma | 800 € | Enquire price |
Gastrointestinal stromal tumor | 800 € | Enquire price |
Breast-, ovarian- and pancreatic carcinoma | 800 € | Enquire price |
Glioblastoma | 800 € | Enquire price |
In 2009, together with her husband, she founded CeGaT GmbH, which is now a leading global provider of gene analyzes for a wide variety of inquiries from medical practice, research and the pharmaceutical industry.
In 2010 she founded the Practice for Human Genetics in Tübingen, today the Center for Human Genetics.
From April 2012 to the end of 2014, Saskia Biskup was the part-time medical director responsible for the Institute for Clinical Genetics at the Olgahospital (Stuttgart Clinic).
From 2015 she then focused 100% on her work in Tübingen. Her main concern is to make diagnostics based on the latest scientific findings available to patients. In the precision medicine of tomorrow, diagnostics is the basis for individualized and targeted therapy. Human genetics plays a central role in this.
She is a Head of Praxis for Human Genetics and a member of Molecular Tumor Board in the University Clinic Tübingen.
Her own research revolves around Parkinson’s disease, and the development of new biomarkers to enable early prediction of neurodegenerative diseases. She was awarded numerous international awards for her researches.
Alexander Golf is a specialist in internal medicine with an additional qualification in hematology and internal oncology, gastroenterology, palliative medicine and emergency medicine.
After gaining recognition in the field of emergency medicine and becoming a specialist in internal medicine, he returned to the Stuttgart Clinic in 2004 as a specialist in hematology and oncology and from 2005 as senior physician. There he built up the palliative medical consultation service and headed the “Geriatric Hematology and Oncology” team.
From 2005 he built up the hematology and oncology section of the Nürtingen clinic and acted as deputy head of the colon cancer center, the oncological center and the medius tumor center of the clinics in the district of Esslingen. From 2015 to 2020 he also worked as deputy head of the oncological focus.
From 2020 to 2022 he headed the medical oncology department at the University Hospital in Tübingen (UKT), worked as senior consultant in internal medicine VIII (medical oncology and pneumology) and acted as spokesman for the center for soft tissue tumors, bone tumors and GIST as well as the interdisciplinary oncology department Tumor Conference (IOK) of the CCC Stuttgart-Tübingen.
In 2005 he began his specialist training in hematology and oncology at the Klinikum Stuttgart, which he continued in the internal department I in the Katharinen- and Bürgerhospital.
From January 2013 he expanded his focus on complementary medicine as senior physician at the Öschelbronn Clinic. He then worked as an employed specialist in the oncology center in Stuttgart at the Liederhalle.
Since 2018 he has been the holder of half a license for specialist medical care in hematology/oncology as part of a special needs license in a joint practice with Dr. Michael Haen in Tubingen. After moving to new premises, saying goodbye to Dr. Haen’s retirement was followed by the founding of a professional practice partnership with Dr. Alexander Golf.
Anja Albers is a specialist in internal medicine and hematology and internal oncology, palliative medicine, emergency medicine – nutritional medicine, acupuncture.
we will contact you within 15 minutes
The CeGaT laboratory in Germany offers a wide range of genetic tests for different purposes:
CeGaT specialists perform research on the latest generation equipment, which the management of CeGaT constantly invests in to improve the quality of tests. Such equipment is the following models:
This is the most modern and powerful genetic diagnostics equipment, allowing doctors to examine biomaterial samples and get the most accurate result within two days.
Genome sequencing is a complex study to obtain complete and accurate genetic information of an organism. Genome sequencing in CeGat is carried out for various purposes, for example:
The CeGaT laboratory in Germany performs various types of cancer tests that help identify genetic factors associated with the onset and development of cancer.
For example:
According to the results of oncological tests, CeGaT specialists give a conclusion with recommendations on therapy methods and prevention.
A DNA test is performed at the CeGaT laboratory in Germany to identify paternity. This is the most accurate and reliable way to determine the biological relationship between father, mother, and child. DNA analysis in CeGat compares genetic markers passed from parents to children. The more matches between markers, the higher the likelihood of paternity.
After receiving DNA samples, the CeGaT laboratory analyzes them using modern sequencing and genotyping methods. The results of Dr. Segat’s DNA test are presented as a report containing information about the probability of paternity, the number of matching markers, statistical indicators, and other data. It takes up to 10 working days to do the test.
To take a paternity test, it is necessary to send samples of biomaterials of the father, mother, and child to the CeGaT laboratory. They can be obtained from saliva, blood, or other biological materials. Special kits are used to take the material which CeGaT employees provide. Biomaterial samples must be properly packaged and protected from damage and contamination. The coordinating doctors at Experts Medical will tell you in more detail about the conditions for collecting and transporting materials and arrange the entire process.
Advantages of DNA testing for establishing paternity in the CeGaT laboratory in Germany:
There are 2 ways to submit biomaterials for genetic research at CeGaT:
It is worth considering that the CeGaT laboratory has clear conditions for the quality and transportation of the material. For some studies, CeGaT workers hand over special transport packages in which they deliver the material. Therefore, contacting the Experts Medical coordinating doctor before taking the tests is recommended for more detailed information on passing specific tests.
Based on the test results, Experts Medical organizes an online consultation with the best-specialized specialists from the world’s leading clinics for further treatment.